Patent · US Active

Methods for producing microRNAs

US8426675B2 · kind B2 · utility

8Cited by
10References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 2011
Grant dateApr 23, 2013
Priority date
Expiry dateJun 7, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to recombinant vectors for inducible and/or tissue specific expression of double-stranded RNA molecules that interfere with the expression of a target gene. In certain embodiments, the invention relates to the use of Tet (tetracycline)-responsive RNA Polymerase II (Pol II) promoters (e.g., TetON or TetOFF) to direct inducible knockdown in certain cells of an integrated or an endogenous gene, such as p53. The invention also relates to a method for producing transgenic animals (e.g., mice) expressing inducible (such as tetracycline-regulated), reversible, and/or tissue-specific double-stranded RNA molecules that interfere with the expression of a target gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.